公司資料
Bio-Path Holdings 股價、新聞與催化劑
- 股票代碼:
- BPTH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年9月21日
—
市值
股價為何變動
截至 2026年9月21日，BPTH 股價變化不大，收於 $0.0002。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Bio-Path Holdings is a biotechnology company focused on RNAi and nucleic-acid-based approaches to cancer. Its story has long centered on specialized oncology science and the challenge of turning it into a commercial asset.
所在地與產業分類
Bio-Path is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商業模式特徵
The company depends on clinical progress, preclinical validation, and capital discipline to keep its programs moving. Investors usually watch readouts, safety, and the ability to sustain runway.
生技產業定位
Bio-Path occupies a niche oncology platform position within biotech. It is highly sensitive to whether its nucleic-acid science can translate into differentiated cancer activity.
未來催化劑
- Bio-Path’s catalysts are liposomal oncology programs and any clinical update that keeps the platform credible. The stock remains highly sensitive to whether the next data point improves the development path.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。